Top Markets
#1 Official Trump Official Trump +37.77%
#2 Tutorial Tutorial +27.67%
#3 Melania Meme Melania Meme +22.70%
#4 Siacoin Siacoin +21.68%
#5 EXOD EXOD +18.93%
#6 MowCat MowCat +18.69%
#7 Unit Pump Unit Pump +16.25%
#8 Pump.fun Pump.fun +16.25%
#9 Mubarak Mubarak +16.22%
#10 Stacks Stacks +16.13%
Coin of the day
Official Trump Official Trump
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Rangering i aksjer #24680
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Aksjekurs
$3.04
Sist synkronisert: 2026-08-21
Markedsverdi
$57.87M
Endring (1 dag)
-1.30%
Endring (1 år)
-74.28%
Land
US
Handel Elicio Therapeutics, Inc. (ELTX)

Kategori

Healthcare
Inntekter for Elicio Therapeutics, Inc. (ELTX)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Elicio Therapeutics, Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Elicio Therapeutics, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH